Zobrazeno 1 - 10
of 34
pro vyhledávání: '"Brian Werneburg"'
Autor:
Alix, Arnaud, Jennifer, Benner, Ellison, Suthoff, Brian, Werneburg, Marcia, Reinhart, Matthew, Sussman, Ronald C, Kessler
Publikováno v:
Journal of Affective Disorders. 325:264-272
While literature has suggested that the duration of a major depressive episode (MDE) may affect both symptomatic and functional outcomes in major depressive disorder (MDD), study designs are limited in their ability to isolate a causal relationship.A
Autor:
Michael Pulley, Samir Macwan, Richard Nowak, Tahseen Mozaffar, Ema Rodrigues, Houari Korideck, Brian Werneburg, Pushpa Narayanaswami
Publikováno v:
Sunday, April 23.
Autor:
Pascal Laforet, David Orlikowski, Guillaume Nicolas, Hélène Prigent, Edouard Berling, Ghislain N’Dah-Sekou, Clarissa Gorin, Ana Júlia Moreira, Juliette Narcy, Angéline Plaud, Emma Touré Cuq, Martin Keller, Brian Werneburg, Emrah Aras, Michael Benatar
Publikováno v:
Tuesday, April 25.
Autor:
Alix M. Arnaud, Teri S. Brister, Ken Duckworth, Phyllis Foxworth, Tonya Fulwider, Ellison D. Suthoff, Brian Werneburg, Izabela Aleksanderek, Marcia L. Reinhart
Publikováno v:
The Primary Care Companion For CNS Disorders. 25
Autor:
Alix M. Arnaud, Teri S. Brister, Ken Duckworth, Phyllis Foxworth, Tonya Fulwider, Ellison D. Suthoff, Brian Werneburg, Izabela Aleksanderek, Marcia L. Reinhart
Publikováno v:
The Journal of Clinical Psychiatry. 83
Autor:
Ellison Suthoff, Mark Kosinski, Alix Arnaud, Paul Hodgkins, Handan Gunduz-Bruce, Robert Lasser, Christopher Silber, Abdul J. Sankoh, Haihong Li, Brian Werneburg, Jeffrey Jonas, James Doherty, Stephen J. Kanes, Vijayveer Bonthapally
Publikováno v:
Journal of affective disorders. 308
Major depressive disorder (MDD), a disabling, potentially life-threatening condition, negatively affects health-related quality of life (HRQoL). This secondary analysis aimed to understand the impact of the neuroactive steroid zuranolone on HRQoL usi
Autor:
Vijayveer Bonthapally, E. Suthoff, Ken O'Day, Kellie Meyer, Paul Hodgkins, Brian Werneburg, Jeffrey Jonas, Alix Arnaud, Katie Stenson
Publikováno v:
Journal of affective disorders. 285
Background Zuranolone (SAGE-217) is a novel, investigational positive allosteric modulator of GABAA receptors being investigated in major depressive disorder (MDD). This analysis of phase 2 data quantified the benefit and risk of zuranolone (30mg) ve
Autor:
Andrew Cutler, Scott T. Aaronson, Gregory W. Mattingly, Samuel T. Wilkinson, Robert Lasser, Indrani Nandy, Brian Werneburg, Jeffrey Jonas, Stephen J. Kanes, Timothy Mariano
Publikováno v:
Biological Psychiatry. 89:S250-S251
Autor:
H. Gunduz-Bruce, James J. Doherty, Stephen Kanes, Kristina M. Deligiannidis, Brian Werneburg, Christopher Silber, Sigui Li, Samantha Meltzer-Brody, Robert Lasser, Andrew Campbell, Jeffrey Jonas, Abdul J. Sankoh
Publikováno v:
JAMA Psychiatry. 78:951
ImportancePostpartum depression (PPD) is one of the most common medical complications during and after pregnancy, negatively affecting both mother and child.ObjectiveTo demonstrate the efficacy and safety of zuranolone, a neuroactive steroid γ-amino
Autor:
Brian Werneburg, De Ren Huang, Javier Zambrano, Barry Hendin, Sheri Rosenblatt, Sibyl Wray, Robert T. Naismith
Publikováno v:
Neurodegenerative Disease Management. 7:39-47
Aim: The objective of this Delphi analysis was to obtain consensus on injection-site reaction (ISR) experience and mitigation strategies for patients with relapsing-remitting multiple sclerosis switching from nonpegylated interferons (IFNs) to pegint